日本新薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/31 | 8,770 | 8,960 | 8,760 | 8,930 | +160 | +1.8% | 143,600 |
2021/08/30 | 8,740 | 8,770 | 8,610 | 8,770 | +50 | +0.6% | 121,500 |
2021/08/27 | 8,810 | 8,830 | 8,640 | 8,720 | -190 | -2.1% | 93,200 |
2021/08/26 | 8,960 | 9,000 | 8,880 | 8,910 | +10 | +0.1% | 140,100 |
2021/08/25 | 8,870 | 8,990 | 8,790 | 8,900 | +80 | +0.9% | 133,700 |
2021/08/24 | 8,800 | 8,920 | 8,780 | 8,820 | +40 | +0.5% | 183,600 |
2021/08/23 | 8,770 | 8,910 | 8,770 | 8,780 | +80 | +0.9% | 128,700 |
2021/08/20 | 8,680 | 8,810 | 8,630 | 8,700 | +170 | +2% | 161,300 |
2021/08/19 | 8,390 | 8,630 | 8,390 | 8,530 | +130 | +1.5% | 147,400 |
2021/08/18 | 8,440 | 8,550 | 8,390 | 8,400 | +50 | +0.6% | 166,600 |
2021/08/17 | 8,380 | 8,480 | 8,320 | 8,350 | ±0 | ±0% | 84,500 |
2021/08/16 | 8,610 | 8,630 | 8,270 | 8,350 | -280 | -3.2% | 157,700 |
2021/08/13 | 8,650 | 8,810 | 8,620 | 8,630 | +20 | +0.2% | 104,900 |
2021/08/12 | 8,760 | 8,770 | 8,480 | 8,610 | -130 | -1.5% | 118,700 |
2021/08/11 | 8,660 | 8,940 | 8,660 | 8,740 | +370 | +4.4% | 242,100 |
2021/08/10 | 8,180 | 8,460 | 8,180 | 8,370 | +160 | +1.9% | 102,300 |
2021/08/06 | 8,230 | 8,310 | 8,190 | 8,210 | -30 | -0.4% | 55,500 |
2021/08/05 | 8,220 | 8,360 | 8,210 | 8,240 | -40 | -0.5% | 78,700 |
2021/08/04 | 8,280 | 8,330 | 8,220 | 8,280 | -70 | -0.8% | 76,200 |
2021/08/03 | 8,300 | 8,380 | 8,250 | 8,350 | -70 | -0.8% | 77,700 |
2021/08/02 | 8,330 | 8,440 | 8,290 | 8,420 | +200 | +2.4% | 91,000 |
2021/07/30 | 8,330 | 8,330 | 8,160 | 8,220 | -230 | -2.7% | 111,700 |
2021/07/29 | 8,550 | 8,580 | 8,410 | 8,450 | -50 | -0.6% | 66,000 |
2021/07/28 | 8,580 | 8,660 | 8,470 | 8,500 | -230 | -2.6% | 137,500 |
2021/07/27 | 8,710 | 8,780 | 8,670 | 8,730 | +40 | +0.5% | 101,300 |
2021/07/26 | 8,620 | 8,720 | 8,620 | 8,690 | +150 | +1.8% | 93,900 |
2021/07/21 | 8,500 | 8,650 | 8,470 | 8,540 | +40 | +0.5% | 72,500 |
2021/07/20 | 8,530 | 8,600 | 8,470 | 8,500 | -40 | -0.5% | 100,000 |
2021/07/19 | 8,530 | 8,600 | 8,480 | 8,540 | -30 | -0.4% | 98,800 |
2021/07/16 | 8,570 | 8,700 | 8,560 | 8,570 | -150 | -1.7% | 74,800 |
2021/07/15 | 8,860 | 8,900 | 8,700 | 8,720 | -40 | -0.5% | 101,200 |
2021/07/14 | 8,750 | 8,860 | 8,710 | 8,760 | -30 | -0.3% | 124,800 |
2021/07/13 | 8,840 | 8,930 | 8,740 | 8,790 | +20 | +0.2% | 97,400 |
2021/07/12 | 8,720 | 8,830 | 8,690 | 8,770 | +190 | +2.2% | 106,300 |
2021/07/09 | 8,450 | 8,610 | 8,410 | 8,580 | -20 | -0.2% | 182,500 |
2021/07/08 | 8,640 | 8,730 | 8,600 | 8,600 | -130 | -1.5% | 143,100 |
2021/07/07 | 8,650 | 8,780 | 8,600 | 8,730 | +70 | +0.8% | 130,400 |
2021/07/06 | 8,760 | 8,760 | 8,660 | 8,660 | -100 | -1.1% | 60,000 |
2021/07/05 | 8,800 | 8,900 | 8,760 | 8,760 | +10 | +0.1% | 90,600 |
2021/07/02 | 8,780 | 8,930 | 8,730 | 8,750 | -30 | -0.3% | 202,400 |
2021/07/01 | 8,800 | 8,800 | 8,670 | 8,780 | -30 | -0.3% | 162,900 |
2021/06/30 | 9,110 | 9,120 | 8,780 | 8,810 | -270 | -3% | 206,400 |
2021/06/29 | 9,050 | 9,120 | 8,950 | 9,080 | ±0 | ±0% | 112,300 |
2021/06/28 | 9,170 | 9,170 | 8,980 | 9,080 | -20 | -0.2% | 192,900 |
2021/06/25 | 9,240 | 9,270 | 9,090 | 9,100 | -140 | -1.5% | 215,500 |
2021/06/24 | 9,300 | 9,360 | 9,190 | 9,240 | +240 | +2.7% | 201,700 |
2021/06/23 | 9,120 | 9,140 | 8,990 | 9,000 | -160 | -1.7% | 163,400 |
2021/06/22 | 9,000 | 9,160 | 8,880 | 9,160 | +180 | +2% | 216,300 |
2021/06/21 | 8,870 | 8,990 | 8,840 | 8,980 | +50 | +0.6% | 146,300 |
2021/06/18 | 8,920 | 8,950 | 8,840 | 8,930 | +80 | +0.9% | 250,300 |
901~
950
件表示中 / 3694件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
日本新薬 | 339,900円 | +7.9% | +8.9% | 3.65% | 7.27倍 | 0.98倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ツムラ | 437,900円 | +20.9% | +87.3% | 3.11% | 9.78倍 | 1.12倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
ペプチド | 190,700円 | +5.0% | +1.5% | 0.00% | 16.37倍 | 4.36倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サワイGHD | 199,300円 | +4.0% | +25.4% | 2.66% | 8.72倍 | 1.15倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 412,000円 | +3.6% | +6.1% | 2.91% | 14.33倍 | 0.84倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム